Lysine-specific histone demethylase 1A (LSD1) in cervical cancer.
Daniel BeilnerChristina KuhnBernd P KostJulia JückstockDoris MayrElisa SchmoeckelChristian DanneckerSven MahnerUdo JeschkeHelene Hildegard HeideggerPublished in: Journal of cancer research and clinical oncology (2020)
Epigenetic changes through enzymes like LSD1 may also be of interest for patients with cervical cancer. A combined therapy with other proteins relayed to cervical cancer like GPER might be of interest for future investigations.